Treasury Chief Reeves Plans Focused Measures on Living Costs in Forthcoming Financial Plan
Chancellor Rachel Reeves has revealed she is planning "targeted measures to deal with household expense issues" in next month's Budget.
Speaking to media outlets, she stated that reducing inflation is a joint responsibility of both the administration and the central bank.
The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this year and next.
Potential Utility Cost Interventions
It is understood the government could take action to lower utility costs, such as by slashing the current 5% level of value-added tax applied on energy supplies.
An additional option is to lower some of the policy costs currently included in household expenses.
Fiscal Limitations and Analyst Predictions
The administration will receive the latest draft from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will show how much room there is for these measures.
The expectation from most economists is that the Chancellor will have to introduce higher taxes or expenditure reductions in order to adhere to her self-imposed debt limits.
Earlier on the same day, calculations suggested there was a £22 billion gap for the Treasury chief to fill, which is at the lower end of projections.
"There's a collective job between the Bank of England and the administration to further reduce some of the sources of price increases," Reeves stated to reporters in the US capital, at the conferences of the IMF and global financial institution.
Revenue Commitments and International Concerns
While much of the focus has been on expected tax increases, the Treasury chief said the most recent figures from the fiscal watchdog had not altered her pledge to campaign commitments not to raise rates on income tax, sales tax or social security contributions.
She blamed an "uncertain global environment" with growing international and trade concerns for the fiscal revenue measures, probably to be targeted on those "wealthiest."
International Economic Disputes
Addressing apprehensions about the United Kingdom's trade ties with China she said: "Our national security invariably take priority."
Last week's announcement by Chinese authorities to increase trade restrictions on rare earths and other resources that are key for high-technology manufacturing led US President Donald Trump to suggest an extra 100% tariff on goods from China, increasing the risk of an all-out commercial conflict between the two largest economies.
The American finance chief described the Chinese move "commercial pressure" and "a international production control attempt."
Questioned on considering the US offer to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's actions and called on the Chinese government "to avoid restrictions and limit trade."
She said the action was "damaging for the world economy and generates additional challenges."
"I believe there are fields where we must address China, but there are also important chances to trade with Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance right."
The Treasury chief also stated she was cooperating with other major economies "regarding our own essential resources approach, so that we are less reliant."
NHS Drug Costs and Funding
Reeves also acknowledged that the price the NHS pays for drugs could go up as a consequence of current talks with the US government and its drugs companies, in return for lower tariffs and funding.
Some of the biggest global drug companies have said in recent statements that they are either halting or abandoning investments in the UK, with some blaming the low prices they are obtaining.
Last month, the Science Minister said the cost the health service spends on medicines would must increase to stop firms and drug research funding departing from the United Kingdom.
The Chancellor stated to media: "We have seen because of the payment system, that medical research, innovative medicines have not been offered in the UK in the manner that they are in other continental states."
"Our aim is to make sure that people getting treatment from the NHS are able to obtain the top life-saving medicines in the globe. And so we are examining this situation, and... looking to secure more capital into the UK."